A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia

[1]  N. Mokhtar,et al.  Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence , 2018, Intestinal research.

[2]  S. Brant,et al.  Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA , 2018, Digestive Diseases and Sciences.

[3]  R. Weersma,et al.  Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies. , 2018, Inflammatory bowel diseases.

[4]  P. Pang,et al.  Epidemiology of Inflammatory Bowel Disease in Southern Peninsular Malaysia. , 2018, The Medical journal of Malaysia.

[5]  W. Lee,et al.  Gut microbiota in early life and its influence on health and disease: A position paper by the Malaysian Working Group on Gastrointestinal Health , 2017, Journal of paediatrics and child health.

[6]  Xia Li,et al.  The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis , 2017, International journal of environmental research and public health.

[7]  J. Fichna,et al.  Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives , 2016, Pharmacological reports : PR.

[8]  S. Wong,et al.  Gastroduodenal Involvement in Asymptomatic Crohn's Disease Patients in Two Areas of Emerging Disease: Asia and Eastern Europe. , 2016, Journal of Crohn's & colitis.

[9]  S. Wong,et al.  Changing epidemiological trends of inflammatory bowel disease in Asia , 2016, Intestinal research.

[10]  Gloria S. Huang,et al.  Designing a broad-spectrum integrative approach for cancer prevention and treatment. , 2015, Seminars in cancer biology.

[11]  Rosalyn A. Jurjus,et al.  Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links , 2015, BBA clinical.

[12]  Harjinder Singh,et al.  A first study on the incidence and prevalence of IBD in Malaysia--results from the Kinta Valley IBD Epidemiology Study. , 2015, Journal of Crohn's & colitis.

[13]  Vibeke Andersen,et al.  Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977–2011 , 2015, The American Journal of Gastroenterology.

[14]  R. Ali.  The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective , 2015, Intestinal research.

[15]  R. Alberts,et al.  Performance of the Montreal classification for inflammatory bowel diseases. , 2014, World journal of gastroenterology.

[16]  S. Ng,et al.  Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific , 2014, Gut.

[17]  S. Palaniappan,et al.  Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future , 2014, Intestinal research.

[18]  C. Justinich,et al.  A tale of two diseases: the history of inflammatory bowel disease. , 2014, Journal of Crohn's & colitis.

[19]  Subrata Ghosh,et al.  Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. , 2013, Gastroenterology.

[20]  S. Ng,et al.  Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. , 2013, Gastroenterology.

[21]  A. Bitton,et al.  Inflammatory bowel disease: a Canadian burden of illness review. , 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[22]  S. Ng,et al.  Inflammatory bowel disease in Asia: A systematic review , 2012, Journal of gastroenterology and hepatology.

[23]  K. Rioux,et al.  Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease , 2011, Therapeutic advances in gastroenterology.

[24]  A. Armuzzi,et al.  IBD: Adalimumab for ulcerative colitis—is the glass half empty or half full? , 2011, Nature Reviews Gastroenterology &Hepatology.

[25]  S. Ganesananthan,et al.  Demography and clinical course of ulcerative colitis in a multiracial Asian population: A nationwide study from Malaysia , 2009, Journal of digestive diseases.

[26]  A. Forbes,et al.  European evidence-based Consensus on the management of ulcerative colitis: Special situations. , 2008, Journal of Crohn's & colitis.

[27]  L. Lix,et al.  The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  C. Bernstein,et al.  Health care resource utilization in inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  K. Goh,et al.  Crohn's disease in adults: observations in a multiracial Asian population. , 2006, World journal of gastroenterology.

[30]  D. Iliopoulos,et al.  Environmental triggers in IBD: a review of progress and evidence , 2018, Nature Reviews Gastroenterology & Hepatology.

[31]  S. Shah,et al.  Perceptions of Malaysian colorectal cancer patients regarding dietary intake: a qualitative exploration. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[32]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[33]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[34]  Judy H Cho,et al.  Inflammatory bowel disease. , 2009, The New England journal of medicine.